ImageneBio Inc.
10/22/2025 | Press release | Distributed by Public on 10/22/2025 07:03
Management Change/Compensation (Form 8-K)
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(c)
On October 21, 2025, the board of directors of ImageneBio, Inc. (the "Company") appointed Kristin Yarema, Ph.D., the Company's Chief Executive Officer, as the Company's interim principal financial officer, effective immediately.
Dr. Yarema's biographical information is set forth under the section titled "Management" in the Company's registration statement on Form S-1(File No. 333-290108),filed with the Securities and Exchange Commission on September 8, 2025, and is incorporated herein by reference.
ImageneBio Inc. published this content on October 22, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on October 22, 2025 at 13:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]